Early human prostate adenocarcinomas harbor androgen-independent cancer cells.

Early human prostate adenocarcinomas harbor androgen-independent cancer cells.

Although blockade of androgen receptor (AR) signaling represents the main treatment for advanced prostate cancer (PrCa), many patients progress to a lethal phenotype of "Castration-Resistant" prostate cancer (CR-PrCa). With the hypothesis that early PrCa may harbor a population of androgen...

Full description

Bibliographic Details
Main Authors: Rita R Fiñones, Jo Yeargin, Melissa Lee, Aman Preet Kaur, Clari Cheng, Paulina Sun, Christopher Wu, Catherine Nguyen, Jessica Wang-Rodriguez, April N Meyer, Stephen M Baird, Daniel J Donoghue, Martin Haas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3783414?pdf=render

Internet

http://europepmc.org/articles/PMC3783414?pdf=render

Similar Items